EP3708165 - Bibliographic data
FORME CRISTALLINE I D'UN COMPOSÉ DE 5-AMINOPYRAZOLE CARBOXAMIDE COMME INHIBITEUR DE BTK
| Last update | 31/05/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
Sinomab Bioscience Limited Unit 303 and 305 To 307
No.15 Science Park Avenue,
Hong Kong Science Park,
Pak Shek Kok
New Territories
Hong Kong 999077
Chine
|
|---|---|
| (72) Inventors |
Yuchuan WU Room 1106 11th Floor Building D
Catic Plaza
BDA
Beijing 100176
Chine
Xi CHEN Room 1106 11th Floor Building D
Catic Plaza
BDA
Beijing 100176
Chine
Shaoqiang HUANG Room 1106 11th Floor Building D
Catic Plaza
BDA
Beijing 100176
Chine
Yonghan HU Room 1106 11th Floor Building D
Catic Plaza
BDA
Beijing 100176
Chine
|
| (74) Agent |
Mail recipient Plasseraud IP 104 Rue de Richelieu
CS92104
75080 Paris Cedex 02
France
|
| (21) Request number | EP18876641.4 |
|---|---|
| (22) Request date | 08/11/2018 |
| (11) Publication number | EP3708165 |
|---|---|
| Publication date | 18/01/2023 |
| (54) Title of the invention | FORME CRISTALLINE I D'UN COMPOSÉ DE 5-AMINOPYRAZOLE CARBOXAMIDE COMME INHIBITEUR DE BTK |
|---|---|
| (51) International classification | C07D 401/14, A61K 31/444, A61P 43/00, A61P 37/02, A61P 7/02, A61P 35/00 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201711104892 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 6 -
Amount: 135 € -
Due date 30/11/2023
Surtax: 6 - Amount: 27 € - Due date 03/06/2024 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 18/01/2023 Entrée en période de grâce du brevet d'invention - Legal date 01/12/2023 Déchéance du brevet d'invention après période de grâce - Legal date 30/11/2023 |